TIMP2 and neuroblastoma: Interestingly, treatment of human neuroblastoma cells with the DNA methyltransferase inhibitor 5-azacytidine (5-AzaC) restored TIMP-2 expression and resulted in a reduction of in vitro invasiveness [31].